Topical pharmaceutical composition in- cluding rel-N- [6 - [ (2R, 6S) - 2, 6 - dimethyl - 4 -morpholinyl] -3 - pyridinyl] - 2 -methyl -41 (trifluoromethoxy) - [1,1' - biphenyl] - 3 - carboxamide

Details for Australian Patent Application No. 2010275240 (hide)

Owner Novartis AG

Inventors Fritze, Andreas; Corcelle, Karine; Grubesa, Melinda Eniko

Agent Davies Collison Cave

Pub. Number AU-A-2010275240

PCT Pub. Number WO2011/009852

Priority 61/295,884 18.01.10 US; 61/227,141 21.07.09 US

Filing date 20 July 2010

Wipo publication date 27 January 2011

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2011/009852 Priority application(s): WO2011/009852

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010275259-Pedal-crank assembly for bicycles

2010275221-Apparatus and method of preserving mucosa